As a leader who has committed much of his career to improving healthcare — an industry that holds millions of people’s lives ...

In a recent interview, Elizabeth Mitchell, president and CEO of the Purchaser Business Group on Health, discussed employers' ...

More than two dozen Black and Latino health tech leaders have endorsed Kamala Harris for president. Another group of over 500 ...

Most Americans don’t understand how an administration's view on healthcare data sharing interoperability could directly ...

At the HLTH conference in Las Vegas, MedCity News Editor-in-Chief Arundhati Parmar, Senior Reporter Katie Adams and Reporter Marissa Plescia interviewed executives who offered their insights on ...

Generative artificial intelligence has taken the world by storm. At the snap of a finger, or a few clacks on the keyboard, anyone with internet access can conjure up academic essays, legal ...

Over the past few years, the metabolic health space has been buzzing due to a mix of increasing awareness, novel drugs and personalized health tools. One of the most impactful developments in ...

What’s wrong with healthcare is often discussed. And indeed, there is no shortage of challenges that the industry faces: healthcare disparities, provider burnout, rising costs, lack of access to ...

At the HLTH conference in Las Vegas, MedCity News Editor-in-Chief Arundhati Parmar and Reporter Marissa Plescia interviewed executives who offered their insights on the shifting healthcare landscape.

While employers are prioritizing mental and physical wellbeing programs, employees report that what they really want is financial wellbeing support, according to a new survey. The survey was ...

Value-based care (VBC) models (which I’ve previously discussed) focus on reducing cost and improving health outcomes for defined “episodes” of care, with the expected cost of these episodes ...

Novo Nordisk was a pioneer in developing GLP-1 drugs for metabolic disorders, but its products are still mainly once-weekly injections. The Danish pharmaceutical giant is putting up $285 million ...